Terms ending in 2030
Every in-force patent on Optinose Inc.'s record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,800,555 | Delivery devices In force · High confidence | OptiNose Inc. | In force | High confidence | |
| US D759,805 | Nosepiece Unit In force · High confidence | OptiNose, Inc. | In force | High confidence | |
| US D761,951 | Nosepiece Unit In force · High confidence | OptiNose, Inc. | In force | High confidence | |
| US 9,649,456 | Nasal Administration In force · High confidence | OptiNose Inc. | In force | High confidence | |
| US 8,899,229 | Powder Delivery Devices In force · High confidence | OptiNose Inc. | In force | High confidence | |
| US 8,978,647 | Nasal Delivery In force · High confidence | OptiNose Inc. | In force | High confidence | |
| US D773,644 | Nosepiece Unit In force · High confidence | OptiNose, Inc. | In force | High confidence | |
| US 10,525,218 | Nasal Delivery Devices In force · High confidence | OptiNose Inc. | In force | High confidence |
8 of 8 patents shown. Soonest term end first, then patent number.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.